(Q44946806)

7 December 2017

Primary levofloxacin resistance and gyrA/B mutations among Helicobacter pylori in Japan (English)

1 reference

7 December 2017

0 references

1 reference

1 reference

Hideyuki Miyachi

1

1 reference

7 December 2017

Ikuya Miki

2

1 reference

7 December 2017

Nobuo Aoyama

3

1 reference

7 December 2017

Daisuke Shirasaka

4

1 reference

7 December 2017

Yuko Matsumoto

5

1 reference

7 December 2017

Masanori Toyoda

6

1 reference

7 December 2017

Toshifumi Mitani

7

1 reference

7 December 2017

Yoshinori Morita

8

1 reference

7 December 2017

Takao Tamura

9

1 reference

7 December 2017

Shohiro Kinoshita

10

1 reference

7 December 2017

Yoshie Okano

11

1 reference

7 December 2017

Shunichi Kumagai

12

1 reference

7 December 2017

Masato Kasuga

13

1 reference

7 December 2017

1 August 2006

1 reference

7 December 2017

1 reference

7 December 2017

11

1 reference

7 December 2017

4

1 reference

7 December 2017

243-249

1 reference

Helicobacter pylori infection and the development of gastric cancer

7 December 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2006.00415.X

Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus Report

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2006.00415.X

Pattern of primary resistance of Helicobacter pylori to metronidazole or clarithromycin in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2006.00415.X

H pylori antibiotic resistance: prevalence, importance, and advances in testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2006.00415.X

Second‐line treatment for failure to eradicate Helicobacter pylori: a randomized trial comparing four treatment strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2006.00415.X

One-week once-daily triple therapy with esomeprazole, levofloxacin and azithromycin compared to a standard therapy for Helicobacter pylori eradication

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2006.00415.X

Basis for the management of drug-resistant Helicobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2006.00415.X

High levels of dual resistance to clarithromycin and metronidazole and in vitro activity of levofloxacin against Helicobacter pylori isolates from patients after failure of therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2006.00415.X

Levofloxacin based triple therapy as a second-line treatment after failure of Helicobacter pylori eradication with standard triple therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2006.00415.X

In vitro activity of fluoroquinolone and the gyrA gene mutation in Helicobacter pylori strains isolated from children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2006.00415.X

A 10-day levofloxacin-based triple therapy in patients who have failed two eradication courses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2006.00415.X

Randomized controlled study of rabeprazole, levofloxacin and rifabutin triple therapy vs. quadruple therapy as second-line treatment for Helicobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2006.00415.X

New once-daily, highly effective rescue triple therapy after multiple Helicobacter pylori treatment failures: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2006.00415.X

Alterations in penicillin-binding protein 1A confer resistance to beta-lactam antibiotics in Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2006.00415.X

Mutations in Helicobacter pylori rdxA gene sequences may not contribute to metronidazole resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2006.00415.X

Real-time PCR assay for rapid and accurate detection of point mutations conferring resistance to clarithromycin in Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2006.00415.X

Second-line treatment of Helicobacter pylori infection after dilution agar methods and PCR-RFLP analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2006.00415.X

Nucleotide sequence of the gyrA gene and characterization of ciprofloxacin-resistant mutants of Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2006.00415.X

Spontaneous mutations that confer antibiotic resistance in Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2006.00415.X

Distribution of fluoroquinolone MICs in Helicobacter pylori strains from Korean patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2006.00415.X

Rapid detection of point mutations in the gyrA gene of Helicobacter pylori conferring resistance to ciprofloxacin by a fluorescence resonance energy transfer-based real-time PCR approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2006.00415.X

Single and double mutations in gyrA but not in gyrB are associated with low- and high-level fluoroquinolone resistance in Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2006.00415.X

Prevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxycillin, tetracycline and trovafloxacin in The Netherlands

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2006.00415.X

Primary and combined resistance to four antimicrobial agents in Helicobacter pylori in Sofia, Bulgaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2006.00415.X

Features and trends in Helicobacter pylori antibiotic resistance in Lisbon area, Portugal (1990-1999).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2006.00415.X

The relationship among previous antimicrobial use, antimicrobial resistance, and treatment outcomes for Helicobacter pylori infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2006.00415.X

In vitro potency of moxifloxacin, clinafloxacin and sitafloxacin against 248 genetically defined clinical isolates of Staphylococcus aureus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2006.00415.X

Interaction between DNA gyrase and quinolones: effects of alanine mutations at GyrA subunit residues Ser(83) and Asp(87).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2006.00415.X

The complete genome sequence of the gastric pathogen Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2006.00415.X

Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2006.00415.X

Helicobacter pylori uptake and efflux: basis for intrinsic susceptibility to antibiotics in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2006.00415.X

Mixed-infection of antibiotic susceptible and resistant Helicobacter pylori isolates in a single patient and underestimation of antimicrobial susceptibility testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2006.00415.X

Helicobacter pylori antibiotic resistance patterns and genotypes in adult dyspeptic patients from a regional population in North Wales

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2006.00415.X

10.1111/J.1523-5378.2006.00415.X

21 January 2018

Identifiers

DOI

1 reference

7 December 2017

1 reference